Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04761328 · ClinicalTrials.gov registry record · NA
Fear of Recurrence and Stopping Immunotherapy
A NA study of Cognitive Behavioral Therapy, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04761328 is a NA study of Cognitive Behavioral Therapy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 100 participants, below the 176-participant average among 8 other Cognitive Behavioral Therapy trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04761328, a NA study of Cognitive Behavioral Therapy, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Conditions Studied
Interventions
- BEHAVIORAL cognitive behavioral therapy
Study Locations (1)
Pennsylvania
- UPMC Hillman Cancer Centers - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04761328
The ClinicalTrials.gov registry entry for NCT04761328 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 8 other Cognitive Behavioral Therapy trials with a reported enrollment target (43% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognitive Behavioral Therapy appearing as the primary indexed condition, and to 1 intervention - of which cognitive behavioral therapy is the first listed.
NCT04761328 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04761328 about?
NCT04761328 is a clinical study titled "Fear of Recurrence and Stopping Immunotherapy". The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
What is the current status of trial NCT04761328?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-08-02. Estimated completion is 2028-12-31.
What conditions does trial NCT04761328 study?
This clinical trial studies the following conditions: Cognitive Behavioral Therapy.
What interventions are being tested in trial NCT04761328?
The interventions under investigation include: cognitive behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04761328?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04761328 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Behavioral Therapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
RECRUITING · NA
-
AI-Based Fidelity Feedback to Enhance CBT
RECRUITING · NA
-
Novel Mental Health Therapies to Improve Military Readiness
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
-
CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.